Evidence map›Paper›PMID 33758384›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2021

Vasoactive medications in extremely low gestational age neonates during the first postnatal week.

Laura E Miller, Matthew M Laughon, Reese H Clark, Kanecia O Zimmerman, Christoph P Hornik, Samia Aleem, P Brian Smith, Rachel G Greenberg

Abstract read
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Use of vasopressors for septic shock in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  6. Impact of Early Hemodynamic Screening on Extremely Preterm Outcomes in a High-Performance Center.American journal of respiratory and critical care medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura E MillerDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0002-2660-6508
Matthew M LaughonDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-4052-3215
Reese H ClarkMEDNAX Center for Research, Education, Quality, and Safety, Sunrise, FL, USA.ORCID http://orcid.org/0000-0002-7363-4640
Kanecia O ZimmermanDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Christoph P HornikDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Samia AleemDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0003-0291-7608
P Brian SmithDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Rachel G GreenbergDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA. rachel.greenberg@duke.edu.ORCID http://orcid.org/0000-0003-4156-8543

Funding

Mentorship of Early-Career Clinicians in Bronchopulmonary Dysplasia Drug TherapiesK24HL143283 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAUGHON, MATTHEW · 2019 to 2023
$613k
NHLBI NIH HHS K24 HL143283
6 · The paper itself

Abstract

objectiveThe management of early hypotension in extremely low gestational age neonates (ELGANs) varies greatly between centers. The objective of this study was to provide updated data on the use of vasoactive medications in ELGANs during the first postnatal week. STUDY

designWe identified ELGANs (22-27 weeks gestational age) cared for at Pediatrix neonatal intensive care units from 2009 to 2018. We evaluated the frequency of exposure to vasoactive medications by gestational age, and compared use of vasoactive medications between two epochs (2009-2013 and 2014-2018).

resultsA total of 10,070/34,234 (29%) ELGANs received ≥1 vasoactive medication. Dopamine was the most frequently used vasoactive medication. The majority (83%) of treated ELGANs initiated therapy on postnatal days 0-1. Overall use of vasoactive medications was slightly lower in 2014-2018 than 2009-2013 (28 vs 31%, p < 0.001).

conclusionA substantial proportion of ELGANs were exposed to vasoactive medications during the first postnatal week.

Indexed as

HypotensionDopamineGestational AgeHumansInfant, NewbornIntensive Care Units, NeonatalDopamine

Identifiers

PMID33758384
PMCPMC9204669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.